Search Results
Dec 08, 2025, 01:36 ET GC Biopharma Ships First Doses of World's First Recombinant Anthrax Vaccine, 'BARYTHRAX inj.'
Biopharma Contacts (Media)Sohee [email protected] Jun[email protected] Na
More news about: GC Biopharma
Dec 07, 2025, 16:30 ET Lilly's Jaypirca (pirtobrutinib) met its primary endpoint in first-of-its-kind, head-to-head Phase 3 study versus Imbruvica (ibrutinib)
doi:10.1016/S0140-6736(21)00224-5Hanel W, Epperla N. Emerging therapies in mantle cell lymphoma. J Hematol Oncol. 2020;13(1):79. Published 2020 Jun 17. doi:10.1186/s13045-020-00914-1Gu D, Tang H, Wu J, Li J, Miao Y. Targeting Bruton tyrosine kinase using non-covalent inhibitors in B cell
More news about: Eli Lilly and Company
Dec 04, 2025, 08:32 ET Pusan National University Researchers Identify the Brain Enzyme That Drives Nicotine Addiction and Smoking Dependence
of the caudate and putamen region of brain, initiating a surge in intracellular calcium. This rise in calcium led to activation of phosphorylated c-Jun N-terminal kinase (pJNK), a signaling molecule known to respond to cellular stress and drug exposure. Once activated, JNK further interacted with the
More news about: Pusan National University
Dec 03, 2025, 21:00 ET 미국임상종양학회, 'ASCO 브레이크스루 2026' 개최 일정 발표
추아(Melvin Chua) 박사, 차기 의장인 마닐라센트럴대학교 로젤 드 구즈만(Roselle De Guzman) 박사, 싱가포르 국립암센터 및 싱가포르종양학회 소속 아일린 푼(Eileen Poon) 박사, 중산대학암센터 및 ASCO 아시아•태평양 지역위원회 대표 마준(Ma Jun) 박사로 구성됐다. 윤옌 박사는 "ASCO 브레이크스루는 학술 연구와 임상 현장을 연결하는 중요한 플랫폼"이라며 "혁신적인 데이터를 국제 무대에서 공유하고, 이를 임상 적용으로 이어갈 수 있는 기회의 장이 될 것"이라고 말했다.ASCO는 인공지능(AI)과
More news about: The American Society of Clinical Oncology
Dec 03, 2025, 21:00 ET American Society of Clinical Oncology (ASCO) announces dates for 2026 ASCO Breakthrough and begins accepting submissions for novel oncology research
Roselle De Guzman, Manila Central University; Dr. Eileen Poon, National Cancer Centre Singapore and the Singapore Society of Oncology, as well as Dr. Jun Ma, Sun Yat-sen University Cancer Centre and ASCO Asia Pacific Regional Council Representative."ASCO Breakthrough is a powerful catalyst where
More news about: The American Society of Clinical Oncology
Dec 03, 2025, 16:56 ET Tendências para 2026: esses são os procedimentos estéticos que estarão em alta para o ano que vem
France9. Markowitz O, et al. Galderma R&D Poster Presentation, IMCAS 2025.10. Weiss RA, et al. Dermatol Surg. 2016 Jun;42(6):699-709 11. Di Gregorio, C et al. Clin Cosmet Investig Dermatol. 2022 Apr 14;15:681-690. 12. Talarico S, et al. Dermatol
More news about: Galderma
Dec 03, 2025, 12:59 ET U.S. FDA approves expanded indication for Lilly's Jaypirca (pirtobrutinib), the first and only non-covalent (reversible) BTK inhibitor, for adults with relapsed or refractory CLL/SLL previously treated with a covalent BTK inhibitor
doi:10.1016/S0140-6736(21)00224-5Hanel W, Epperla N. Emerging therapies in mantle cell lymphoma. J Hematol Oncol. 2020;13(1):79. Published 2020 Jun 17. doi:10.1186/s13045-020-00914-1Gu D, Tang H, Wu J, Li J, Miao Y. Targeting Bruton tyrosine kinase using non-covalent inhibitors in B cell
More news about: Eli Lilly and Company
Dec 03, 2025, 10:00 ET Services PMI® at 52.6%; November 2025 ISM® Services PMI® Report
52.8Jun 202550.8
More news about: Institute for Supply Management
Dec 02, 2025, 21:23 ET Daewoong Pharmaceutical Holds Nabota Master Class in Saudi Arabia
workshops into a global education ecosystem that strengthens clinical expertise, fosters scientific exchange, and enhances brand credibility.Jun-soo Yun, Head of Daewoong Pharmaceutical's Nabota Business Division, commented, "NMC MENA was more than a training event—it was a milestone moment where
More news about: Daewoong Pharmaceutical Co., Ltd.
Dec 02, 2025, 07:00 ET Lynk Pharmaceuticals Announces FDA IND Approval of Its Allosteric TYK2 Inhibitor LNK01006
promising molecule into human clinical trials and bringing new therapeutic options to treat patients suffering from neurodegenerative diseases."Dr. Jun Wang, Co-founder and Chief Scientific Officer of Lynk Pharmaceuticals, said, "LNK01006 is a novel brain-penetrant allosteric TYK2 inhibitor designed
More news about: Lynk Pharmaceuticals Co., Ltd.
Dec 02, 2025, 06:42 ET Prefilled Syringes (PFS) Market Size to Grow USD 32.98 Billion by 2035 at a CAGR 13.75 | Vantage Market Research
therapies.Mar 2025: Global pharma–CDMO partnerships expand integrated fill-finish capacity for vaccines and monoclonal antibodies.Jun 2025: Rollout of next-generation safety-engineered prefilled syringes with passive needlestick protection.Aug 2025: Growth of digital
More news about: Vantage Market Research
Dec 02, 2025, 00:00 ET GC Biopharma's Varicella Vaccine Strain 'MAV/06' Listed in WHO Position Paper
Biopharma Contacts (Media)Sohee [email protected] Jun[email protected] Na
More news about: GC Biopharma
Dec 01, 2025, 10:00 ET Manufacturing PMI® at 48.2%; November 2025 ISM® Manufacturing PMI® Report
50.9Jun 202549.0
More news about: Institute for Supply Management
Nov 27, 2025, 00:00 ET GC Genome Publishes Blood-Based Colorectal Cancer Screening Study in the American Journal of Gastroenterology
Genome Contacts (Media)Sohee [email protected] Jun[email protected] Na
More news about: GC Genome
Nov 26, 2025, 20:00 ET Beyless Achieves ASPICE CL2 Certification for In-Vehicle System Software Quality
a repeatable and sustainable quality management framework and has reached a level capable of meeting the quality demands of global OEMs.Hyung-Jun Kim, CEO of Beyless, stated, "This certification is an important milestone that demonstrates our capabilities as a global leader in mobility software.
More news about: BEYLESS Co.,Ltd.
Nov 26, 2025, 20:00 ET Beyless erhält ASPICE CL2-Zertifizierung für die Qualität seiner Fahrzeugsystemsoftware
Qualitätsmanagement-Framework sichergestellt hat und ein Niveau erreicht hat, das den Qualitätsanforderungen globaler OEMs gerecht wird.Hyung-Jun Kim, CEO von Beyless, erklärte: „Diese Zertifizierung ist ein wichtiger Meilenstein, der unsere Fähigkeiten als weltweit führender Anbieter von Mobilitätssoftware
More news about: BEYLESS Co.,Ltd.
Nov 26, 2025, 20:00 ET Beyless Achieves ASPICE CL2 Certification for In-Vehicle System Software Quality
a repeatable and sustainable quality management framework and has reached a level capable of meeting the quality demands of global OEMs.Hyung-Jun Kim, CEO of Beyless, stated, "This certification is an important milestone that demonstrates our capabilities as a global leader in mobility software.
More news about: BEYLESS Co.,Ltd.
Nov 26, 2025, 07:24 ET La draga de succión trasera ultra grande patentada de China Tong Jun completa con éxito las pruebas en el mar
SHANGHÁI, 26 de noviembre de 2025 /PRNewswire/ -- El 25 de noviembre, la Tong Jun, una draga de 35 000 metros cúbicos con tolva de succión trasera ultragrande construida por Shanghai Zhenhua Heavy Industries (ZPMC) para CCCC Tianjin
More news about: ZPMC
Nov 26, 2025, 05:12 ET Supreme Court of Singapore and Supreme People's Court of China Strengthen Bilateral Ties at Ninth Singapore-China Legal and Judicial Roundtable
Menon, was on a two-day visit to Shenzhen from 17 to 18 November 2025. The Roundtable was co-chaired by Chief Justice Menon and His Excellency Zhang Jun, Chief Justice of the SPC. The two Chief Justices also held their annual Singapore-China Chief Justices Bilateral Meeting during the visit.Established
More news about: Supreme Court of Singapore
Nov 26, 2025, 01:15 ET Chinas firmeneigener Ultra-Large Trailing Suction Hopper Dredger Tong Jun schließt Seeerprobung erfolgreich ab
SHANGHAI, 26. November 2025 /PRNewswire/ -- Am 25. November schloss die Tong Jun, ein von Shanghai Zhenhua Heavy Industries (ZPMC) für CCCC Tianjin Dredging Co., Ltd. gebauter 35.000 Kubikmeter großer Schleppsaugbagger, erfolgreich
More news about: ZPMC
Nov 25, 2025, 22:27 ET China's Proprietary Ultra-Large Trailing Suction Hopper Dredger Tong Jun Successfully Completes Sea Trials
SHANGHAI, Nov. 26, 2025 /PRNewswire/ -- On November 25, the Tong Jun, a 35,000-cubic-meter ultra-large trailing suction hopper dredger built by Shanghai Zhenhua Heavy Industries (ZPMC) for CCCC Tianjin Dredging Co.,
More news about: ZPMC
Nov 25, 2025, 11:09 ET S&P COTALITY CASE-SHILLER INDEX REPORTS ANNUAL GAIN IN SEPTEMBER 2025
226.29Jun-06146.45
More news about: S&P Dow Jones Indices
Nov 25, 2025, 04:35 ET TCL CSOT Unveils "2025 Eye-Care Technology White Paper", Setting New Benchmarks for Natural-Light Display Standards
Approach to Redefine Eye Health Display StandardsAt 2025 TCL CSOT Global Display Tech-Ecosystem Conference (DTC 2025), Jun Zhao, Senior Vice President of TCL Technology and CEO of TCL CSOT, emphasized that eye health should be the industry's fundamental standard rather
More news about: TCL China Star Optoelectronics Technology
Nov 24, 2025, 12:00 ET Lilly to present data from two positive Phase 3 studies of Jaypirca (pirtobrutinib) in chronic lymphocytic leukemia at the 2025 American Society of Hematology (ASH) Annual Meeting
pirtobrutinib exposure. Reduce Jaypirca dosage in patients with severe renal impairment according to approved labeling. PT HCP ISI MCL_CLL AA JUN2024Please see
More news about: Eli Lilly and Company
Nov 24, 2025, 09:06 ET DEADLINE APPROACHING: Berger Montague Advises Cepton, Inc. (NASDAQ: CPTN) Investors to Inquire About a Securities Fraud Class Action by December 8, 2025
not disclose its existence to shareholders in proxy materials for the Koito acquisition.The lawsuit also alleges that Cepton CEO Jun Pei had significant conflicts of interest that influenced the Board's decision-making process. Investors learned the truth about Cepton through documents
More news about: Berger Montague